论文部分内容阅读
目的观察早期应用呋塞米静脉滴注联合小剂量多巴胺治疗心力衰竭的临床效果及其安全性。方法随机将62例心力衰竭患者分为两组:对照组(30例)予以单纯呋塞米静脉滴注治疗,治疗组(32例)予以呋塞米联合小剂量多巴胺静脉滴注治疗,比较两组患者临床治疗效果。结果治疗组左室射血分数及6min距步行距离改善情况均优于对照组,且差异有统计学意义(P<0.05);治疗组及对照组治疗总有效率分别为87.5%、70.0%,差异有统计学意义(P<0.05)。结论早期应用呋塞米联合小剂量多巴胺治疗心力衰竭临床疗效及安全性良好,优于单独使用呋塞米。
Objective To observe the clinical effect and safety of intravenous drip of furosemide in combination with low-dose dopamine in the treatment of heart failure. Methods Sixty-two patients with heart failure were randomly divided into two groups: the control group (30 cases) was treated with intravenous furosemide only, the treatment group (32 cases) was treated with furosemide plus low-dose dopamine intravenous infusion, compared with two Group of patients with clinical treatment. Results The improvement of left ventricular ejection fraction and walking distance at 6 minutes in treatment group were better than that in control group (P <0.05). The total effective rates of treatment group and control group were 87.5% and 70.0% The difference was statistically significant (P <0.05). Conclusion Early use of furosemide combined with low-dose dopamine in the treatment of heart failure has good clinical efficacy and safety, superior to furosemide alone.